PIPELINE
Our products and pipeline
Early cancer
screening
GASTROClear Test
The world's first RNA blood test for early detection of gastric cancer
In the pipeline:
5 tests for early cancer detection:
0%
Gastric Cancer
0%
Lung Cancer
0%
Breast Cancer
0%
Colorectal Cancer
0%
Ovarian Cancer
0%
Liver Cancer
Infectious, cardiovascular, and metabolic diseases
Fortitude Kit
A SARS-CoV-2 RT-PCR test for accurate testing of COVID-19
In the pipeline:
1 test for
infectious disease.
3 tests for cardiovascular and metabolic diseases.
0%
COVID-19
0%
Heart Failure
0%
Pulmonary Hypertension
0%
Sepsis
0%
Insulin Resistance
Discovery and
development
ID3EAL Suite
Versatile market-leading microRNA research solutions for scientists
In the pipeline:
1 new ID3EAL microRNA knowledge panel.
0%
Cancer microRNA Panel
0%
Biofluid microRNA Panel
0%
PanoramiR Disease Relevant Panel
0%
Viral microRNA Panel
Our end-to-end solutions
Discover
Research & development
- Tools for RNA-centric discovery.
- Solving unmet needs in cancer, cardiovascular, metabolic, and infectious diseases.
Develop
Manufacturing & commercialization
- ISO 13485 certified, Industry 4.0 diagnostics manufacturing.
- Bringing high quality products to market at affordable cost.
Diagnose
Clinical
service
- Multi-omics testing for novel insights, improved early screening, and precision medicine.
- Delivering accurate results.
Deliver
Healthcare solutions
- Promote dynamic prevention to improve healthcare and health economics.
- Partnering Insurtech and Telehealth